This inventor holds 18 USPTO granted patents and 28 published patent applications, plus 5 CIPO patents and 6 EPO patents, primarily in HCV Treatment. Top assignees: Abbvie Inc., Abbott Laboratories Corporation, Abbott Research B.v.. Active years: 2003-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Waukegan, IL (US) (2003 - 2004)
- Gurnee, IL (2013)
- Gurnee, IL (US) (2012 - 2016)
- Lincolnshire, IL (US) (2015 - 2022)
Company Filing History:
11 out of 827 
5 out of 4,190 
1 out of 3 Years Active: 2003-2022
Areas of Expertise:
Title: Sandeep Dutta: Innovator in Hepatitis C Treatment
Introduction
Sandeep Dutta, an esteemed inventor hailing from Gurnee, Illinois, has made significant strides in the field of medical innovation. With a remarkable portfolio of 18 patents, Dutta’s work focuses primarily on the treatment of Hepatitis C virus (HCV), contributing to advancements in pharmacological therapies.
Latest Patents
Dutta's latest inventions revolve around methods for treating HCV through interferon-free therapies. His innovative treatments aim to shorten the duration of therapy to no more than 12 weeks. This approach includes administering at least two direct-acting antiviral agents to individuals infected with HCV, specifically avoiding the inclusion of interferon or ribavirin. The treatment protocol emphasizes the use of at least one of the two compounds, referred to as Compound 1 and Compound 2, along with their pharmaceutically acceptable salts.
Career Highlights
Throughout his career, Sandeep Dutta has been associated with major pharmaceutical companies. He has contributed his expertise to notable organizations such as AbbVie Inc. and Abbott Laboratories. His extensive work in these esteemed companies has been pivotal in advancing therapeutic strategies against viral infections.
Collaborations
Dutta has also collaborated with several accomplished professionals in the field. Some of his notable coworkers include Walid M. Awni and Barry M. Bernstein. These partnerships have fostered a dynamic exchange of ideas and innovations, driving forward the mission of enhancing treatment efficacy for patients.
Conclusion
In summary, Sandeep Dutta stands out as a pivotal figure in the realm of medical inventions, particularly through his targeted advancements in the treatment of Hepatitis C. His dedication to developing effective, innovative therapies has the potential to revolutionize patient care, showcasing the critical role of inventors in improving global health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile